Icon Cancer Centre Farrer Park

Singapore 217562

0 studies enrolling now · 5 studies all time

What they study most

Advanced Non Small Cell Lung Cancer, Gastric Adenocarcinoma, Gastric Cancer, Gastroesophageal Junction Adenocarcinoma, Head and Neck Cancer, Locally Advanced or Metastatic Unresectable Urothelial Cancer, Melanoma, Metastatic Breast Cancer, Metastatic Non Small Cell Lung Cancer, Non-Small Cell Lung Cancer, Renal Cell Carcinoma, Resectable Non-Small-Cell Lung Cancer

Studies at this site

• Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist) — Recruiting now
• A Study to Evaluate the Efficacy and Safety of Inavolisib in Combination With Phesgo Versus Placebo in Combination With Phesgo in Participants With PIK3CA-Mutated HER2-Positive Locally Advanced or Metastatic Breast Cancer — Recruiting now
• Study of Sacituzumab Govitecan Versus Physician's Choice of Treatment in Participants With Urothelial Cancer That Cannot Be Removed or Has Spread — Completed
• A Study of Evorpacept (ALX148) in Patients With Advanced HER2+ Gastric Cancer (ASPEN-06) — Running, not enrolling
• Phase 3 Study of MRTX849 (Adagrasib) vs Docetaxel in Patients With Advanced Non-Small Cell Lung Cancer With KRAS G12C Mutation — Running, not enrolling